| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Damage | 41 | 2024 | 2458 | 4.390 |
Why?
|
| Fibrinolysis | 7 | 2024 | 331 | 3.590 |
Why?
|
| Cell Cycle Proteins | 51 | 2022 | 3458 | 3.170 |
Why?
|
| Tissue Plasminogen Activator | 9 | 2024 | 1163 | 2.950 |
Why?
|
| Tranexamic Acid | 5 | 2020 | 174 | 2.870 |
Why?
|
| Signal Transduction | 79 | 2024 | 23631 | 2.810 |
Why?
|
| Neutrophils | 20 | 2024 | 3785 | 2.360 |
Why?
|
| Antifibrinolytic Agents | 5 | 2020 | 289 | 2.300 |
Why?
|
| 14-3-3 Proteins | 28 | 2014 | 222 | 2.180 |
Why?
|
| Mitosis | 23 | 2023 | 1190 | 2.080 |
Why?
|
| Protein Kinases | 23 | 2018 | 1609 | 1.990 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 24 | 2021 | 2890 | 1.950 |
Why?
|
| Phosphopeptides | 15 | 2015 | 240 | 1.940 |
Why?
|
| Wounds and Injuries | 11 | 2021 | 2514 | 1.870 |
Why?
|
| Phosphoserine | 16 | 2023 | 204 | 1.840 |
Why?
|
| Phosphorylation | 72 | 2024 | 8326 | 1.720 |
Why?
|
| Amino Acid Motifs | 33 | 2024 | 929 | 1.670 |
Why?
|
| Plasminogen | 3 | 2024 | 144 | 1.640 |
Why?
|
| Cell Cycle | 20 | 2019 | 2938 | 1.620 |
Why?
|
| Protein Structure, Tertiary | 41 | 2015 | 3779 | 1.610 |
Why?
|
| Phosphothreonine | 14 | 2023 | 62 | 1.570 |
Why?
|
| Phosphoproteins | 27 | 2024 | 2448 | 1.520 |
Why?
|
| Tyrosine 3-Monooxygenase | 15 | 2004 | 370 | 1.500 |
Why?
|
| Peptide Library | 24 | 2013 | 350 | 1.450 |
Why?
|
| Leukocyte Elastase | 2 | 2024 | 114 | 1.420 |
Why?
|
| Proto-Oncogene Proteins | 28 | 2022 | 4526 | 1.420 |
Why?
|
| Reactive Oxygen Species | 8 | 2022 | 2146 | 1.420 |
Why?
|
| Substrate Specificity | 26 | 2024 | 1753 | 1.410 |
Why?
|
| Blood Coagulation Disorders | 4 | 2020 | 350 | 1.310 |
Why?
|
| DNA Repair | 16 | 2024 | 2048 | 1.230 |
Why?
|
| Proteins | 23 | 2019 | 6006 | 1.190 |
Why?
|
| Tumor Suppressor Protein p53 | 10 | 2020 | 2952 | 1.150 |
Why?
|
| DNA Breaks, Double-Stranded | 4 | 2024 | 608 | 1.110 |
Why?
|
| Protein Interaction Mapping | 9 | 2016 | 612 | 1.080 |
Why?
|
| Molecular Biology | 4 | 2019 | 573 | 1.050 |
Why?
|
| Protein Binding | 48 | 2022 | 9343 | 1.030 |
Why?
|
| Thrombelastography | 4 | 2020 | 194 | 1.020 |
Why?
|
| Coronavirus Infections | 7 | 2020 | 3118 | 0.970 |
Why?
|
| Transcription Factors | 30 | 2020 | 12166 | 0.960 |
Why?
|
| Pneumonia, Viral | 7 | 2020 | 3241 | 0.960 |
Why?
|
| Apoptosis | 22 | 2020 | 9516 | 0.930 |
Why?
|
| Evolution, Molecular | 8 | 2024 | 1893 | 0.900 |
Why?
|
| Models, Molecular | 43 | 2021 | 5404 | 0.890 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 10 | 2019 | 692 | 0.880 |
Why?
|
| RNA, Ribosomal | 1 | 2024 | 227 | 0.880 |
Why?
|
| Systems Biology | 6 | 2012 | 479 | 0.860 |
Why?
|
| Models, Biological | 22 | 2020 | 9493 | 0.850 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2024 | 279 | 0.840 |
Why?
|
| G2 Phase | 5 | 2010 | 136 | 0.840 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2023 | 121 | 0.820 |
Why?
|
| Binding Sites | 39 | 2015 | 6017 | 0.810 |
Why?
|
| Phosphatidylinositol Phosphates | 6 | 2008 | 201 | 0.810 |
Why?
|
| CDC2 Protein Kinase | 5 | 2020 | 212 | 0.800 |
Why?
|
| Respiratory Insufficiency | 2 | 2021 | 1241 | 0.800 |
Why?
|
| Fibrinolytic Agents | 6 | 2024 | 2074 | 0.770 |
Why?
|
| Mitogen-Activated Protein Kinases | 9 | 2014 | 1246 | 0.760 |
Why?
|
| Computational Biology | 17 | 2019 | 3543 | 0.760 |
Why?
|
| Nuclear Proteins | 20 | 2024 | 5800 | 0.730 |
Why?
|
| Angiogenic Proteins | 1 | 2021 | 101 | 0.710 |
Why?
|
| Health Services Administration | 1 | 2020 | 63 | 0.680 |
Why?
|
| Animals | 120 | 2024 | 169337 | 0.680 |
Why?
|
| RNA Interference | 9 | 2020 | 2836 | 0.680 |
Why?
|
| cdc25 Phosphatases | 8 | 2010 | 60 | 0.670 |
Why?
|
| Crystallography, X-Ray | 17 | 2020 | 1952 | 0.660 |
Why?
|
| src Homology Domains | 14 | 2024 | 362 | 0.660 |
Why?
|
| Fluorouracil | 1 | 2024 | 1655 | 0.650 |
Why?
|
| Neovascularization, Pathologic | 2 | 2021 | 2635 | 0.650 |
Why?
|
| Enzyme Activation | 17 | 2022 | 3587 | 0.640 |
Why?
|
| Research | 3 | 2020 | 1981 | 0.640 |
Why?
|
| Blood Coagulation | 4 | 2020 | 1161 | 0.640 |
Why?
|
| Amino Acid Sequence | 52 | 2015 | 13423 | 0.640 |
Why?
|
| Shock, Hemorrhagic | 1 | 2020 | 224 | 0.630 |
Why?
|
| Threonine | 5 | 2023 | 274 | 0.630 |
Why?
|
| Complement Activation | 1 | 2020 | 447 | 0.630 |
Why?
|
| Complement C5a | 1 | 2019 | 100 | 0.630 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2012 | 615 | 0.620 |
Why?
|
| Proteomics | 16 | 2024 | 3906 | 0.620 |
Why?
|
| RNA Stability | 2 | 2011 | 321 | 0.620 |
Why?
|
| Biomedical Research | 6 | 2019 | 3464 | 0.620 |
Why?
|
| Humans | 221 | 2024 | 768393 | 0.610 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2018 | 87 | 0.610 |
Why?
|
| Cell Division | 5 | 2020 | 4479 | 0.600 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2011 | 393 | 0.600 |
Why?
|
| Growth Inhibitors | 1 | 2019 | 375 | 0.600 |
Why?
|
| Angiostatins | 1 | 2017 | 64 | 0.600 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2015 | 69 | 0.590 |
Why?
|
| Peptides | 19 | 2022 | 4353 | 0.580 |
Why?
|
| Cytokines | 7 | 2021 | 7445 | 0.580 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 906 | 0.580 |
Why?
|
| Catalytic Domain | 2 | 2018 | 698 | 0.570 |
Why?
|
| HeLa Cells | 25 | 2022 | 3088 | 0.570 |
Why?
|
| Cell Line, Tumor | 29 | 2024 | 17135 | 0.560 |
Why?
|
| Tyrosine | 5 | 2024 | 1428 | 0.560 |
Why?
|
| Pandemics | 8 | 2021 | 8753 | 0.560 |
Why?
|
| RNA, Small Interfering | 13 | 2020 | 3434 | 0.550 |
Why?
|
| Neoplasms | 16 | 2020 | 22385 | 0.550 |
Why?
|
| Pyroglyphidae | 1 | 2017 | 93 | 0.540 |
Why?
|
| Receptors, Androgen | 1 | 2023 | 1083 | 0.530 |
Why?
|
| DNA-Binding Proteins | 23 | 2020 | 9614 | 0.530 |
Why?
|
| Exonucleases | 2 | 2007 | 42 | 0.530 |
Why?
|
| Proteome | 10 | 2024 | 1881 | 0.520 |
Why?
|
| Phosphotyrosine | 5 | 2024 | 458 | 0.520 |
Why?
|
| Cytoplasm | 5 | 2010 | 1502 | 0.520 |
Why?
|
| Shock | 1 | 2018 | 316 | 0.520 |
Why?
|
| Genetics, Medical | 1 | 2019 | 334 | 0.520 |
Why?
|
| Neoplasm Proteins | 5 | 2018 | 3610 | 0.520 |
Why?
|
| MAP Kinase Signaling System | 7 | 2023 | 1493 | 0.510 |
Why?
|
| Sequence Analysis, Protein | 4 | 2004 | 265 | 0.510 |
Why?
|
| S Phase | 5 | 2020 | 424 | 0.500 |
Why?
|
| High-Throughput Screening Assays | 5 | 2017 | 937 | 0.490 |
Why?
|
| Xenopus Proteins | 2 | 2011 | 435 | 0.490 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2015 | 1169 | 0.480 |
Why?
|
| RNA, Messenger | 9 | 2015 | 12805 | 0.480 |
Why?
|
| Mice | 64 | 2024 | 82017 | 0.470 |
Why?
|
| Thrombolytic Therapy | 2 | 2020 | 2050 | 0.470 |
Why?
|
| Histidine | 5 | 2018 | 302 | 0.470 |
Why?
|
| Phosphotransferases | 2 | 2015 | 302 | 0.460 |
Why?
|
| Bombs | 1 | 2014 | 73 | 0.460 |
Why?
|
| Protein Biosynthesis | 6 | 2011 | 2094 | 0.460 |
Why?
|
| Molecular Sequence Data | 47 | 2015 | 17626 | 0.460 |
Why?
|
| Antineoplastic Agents | 14 | 2020 | 13697 | 0.460 |
Why?
|
| Tubulin | 8 | 2019 | 695 | 0.450 |
Why?
|
| Neutrophil Activation | 5 | 2021 | 180 | 0.450 |
Why?
|
| RNA-Binding Proteins | 3 | 2020 | 1883 | 0.450 |
Why?
|
| Protein Conformation | 22 | 2013 | 3955 | 0.450 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 857 | 0.450 |
Why?
|
| Disaster Medicine | 1 | 2014 | 75 | 0.440 |
Why?
|
| DNA Replication | 2 | 2020 | 1428 | 0.440 |
Why?
|
| Protein Processing, Post-Translational | 6 | 2016 | 1967 | 0.440 |
Why?
|
| Cisplatin | 4 | 2020 | 1661 | 0.440 |
Why?
|
| Saccharomyces cerevisiae Proteins | 9 | 2015 | 1836 | 0.430 |
Why?
|
| Salvage Therapy | 1 | 2020 | 1277 | 0.430 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2011 | 2812 | 0.430 |
Why?
|
| Databases, Protein | 7 | 2015 | 385 | 0.430 |
Why?
|
| Drug Design | 3 | 2021 | 1046 | 0.420 |
Why?
|
| Critical Illness | 4 | 2020 | 2755 | 0.420 |
Why?
|
| Cytokinesis | 4 | 2020 | 170 | 0.420 |
Why?
|
| Cell Biology | 1 | 2013 | 92 | 0.420 |
Why?
|
| Traumatology | 1 | 2013 | 101 | 0.400 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2721 | 0.400 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2014 | 798 | 0.400 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 633 | 0.390 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 1890 | 0.390 |
Why?
|
| Terrorism | 1 | 2014 | 211 | 0.390 |
Why?
|
| Protein Isoforms | 7 | 2013 | 1703 | 0.390 |
Why?
|
| Casein Kinase II | 2 | 2012 | 121 | 0.390 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 6971 | 0.390 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2024 | 168 | 0.380 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 378 | 0.380 |
Why?
|
| Serine | 8 | 2023 | 831 | 0.380 |
Why?
|
| Cell Nucleus | 13 | 2012 | 2886 | 0.370 |
Why?
|
| Cell Line | 32 | 2023 | 15597 | 0.370 |
Why?
|
| Rad51 Recombinase | 1 | 2012 | 191 | 0.370 |
Why?
|
| Research Support as Topic | 2 | 2020 | 696 | 0.370 |
Why?
|
| Respiratory Burst | 3 | 2023 | 110 | 0.370 |
Why?
|
| Biology | 1 | 2013 | 292 | 0.360 |
Why?
|
| Centrosome | 3 | 2011 | 210 | 0.360 |
Why?
|
| Mass Casualty Incidents | 1 | 2013 | 180 | 0.360 |
Why?
|
| Carrier Proteins | 12 | 2024 | 4936 | 0.350 |
Why?
|
| Protein Kinase C | 3 | 2007 | 1207 | 0.350 |
Why?
|
| Thrombosis | 2 | 2021 | 2955 | 0.350 |
Why?
|
| Periodicals as Topic | 2 | 2013 | 1469 | 0.340 |
Why?
|
| Pyrimidines | 3 | 2019 | 3048 | 0.340 |
Why?
|
| RNA | 3 | 2010 | 2726 | 0.340 |
Why?
|
| Fibrinolysin | 2 | 2020 | 130 | 0.340 |
Why?
|
| Gene Expression Profiling | 8 | 2019 | 9510 | 0.330 |
Why?
|
| Database Management Systems | 1 | 2011 | 257 | 0.330 |
Why?
|
| Microfilament Proteins | 4 | 2019 | 1135 | 0.330 |
Why?
|
| Macrocyclic Compounds | 3 | 2021 | 67 | 0.330 |
Why?
|
| Feedback, Physiological | 5 | 2011 | 481 | 0.330 |
Why?
|
| Ligands | 12 | 2013 | 3283 | 0.330 |
Why?
|
| Chemotaxis | 3 | 2021 | 600 | 0.320 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2019 | 1813 | 0.320 |
Why?
|
| Acyltransferases | 11 | 2019 | 306 | 0.320 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 632 | 0.310 |
Why?
|
| Disaster Planning | 1 | 2014 | 560 | 0.310 |
Why?
|
| Reproducibility of Results | 6 | 2015 | 20224 | 0.300 |
Why?
|
| Superoxides | 3 | 2008 | 389 | 0.300 |
Why?
|
| Hemorrhage | 4 | 2021 | 3461 | 0.300 |
Why?
|
| Mutation | 16 | 2020 | 30228 | 0.300 |
Why?
|
| Osteosarcoma | 3 | 2018 | 911 | 0.300 |
Why?
|
| Health Policy | 1 | 2020 | 2698 | 0.300 |
Why?
|
| HEK293 Cells | 9 | 2024 | 4291 | 0.300 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 275 | 0.290 |
Why?
|
| Gene Expression | 1 | 2020 | 7598 | 0.290 |
Why?
|
| Software | 7 | 2015 | 4453 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 3 | 2019 | 2830 | 0.290 |
Why?
|
| RNA Splicing | 2 | 2017 | 903 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2021 | 8634 | 0.280 |
Why?
|
| Mathematics | 1 | 2008 | 704 | 0.280 |
Why?
|
| Glioma | 3 | 2018 | 3526 | 0.280 |
Why?
|
| Allosteric Site | 2 | 2018 | 105 | 0.280 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2024 | 2433 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 637 | 0.280 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 2544 | 0.280 |
Why?
|
| Ubiquitination | 4 | 2024 | 1009 | 0.270 |
Why?
|
| Azepines | 2 | 2019 | 329 | 0.270 |
Why?
|
| Sequence Homology, Amino Acid | 12 | 2014 | 2750 | 0.270 |
Why?
|
| Chromatin | 2 | 2020 | 2968 | 0.260 |
Why?
|
| Peer Review, Research | 1 | 2009 | 344 | 0.260 |
Why?
|
| Sequence Alignment | 10 | 2006 | 2176 | 0.260 |
Why?
|
| p21-Activated Kinases | 4 | 2019 | 127 | 0.260 |
Why?
|
| Prodrugs | 4 | 2014 | 275 | 0.260 |
Why?
|
| Thrombin | 2 | 2019 | 600 | 0.260 |
Why?
|
| BRCA1 Protein | 6 | 2009 | 1155 | 0.260 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2007 | 237 | 0.260 |
Why?
|
| Peptides, Cyclic | 2 | 2022 | 391 | 0.260 |
Why?
|
| Histones | 6 | 2015 | 2592 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 14 | 2024 | 22355 | 0.250 |
Why?
|
| HCT116 Cells | 4 | 2020 | 405 | 0.250 |
Why?
|
| Immunoprecipitation | 8 | 2012 | 874 | 0.250 |
Why?
|
| Adenosine Triphosphate | 6 | 2020 | 2002 | 0.250 |
Why?
|
| Mice, Knockout | 10 | 2021 | 14481 | 0.250 |
Why?
|
| Protein Transport | 5 | 2012 | 1958 | 0.250 |
Why?
|
| Recombinant Fusion Proteins | 11 | 2009 | 3731 | 0.240 |
Why?
|
| Genomics | 4 | 2021 | 5916 | 0.240 |
Why?
|
| Oligopeptides | 3 | 2000 | 1194 | 0.240 |
Why?
|
| Fanconi Anemia Complementation Group L Protein | 1 | 2024 | 6 | 0.240 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2006 | 1671 | 0.240 |
Why?
|
| Structure-Activity Relationship | 9 | 2022 | 3055 | 0.230 |
Why?
|
| Congresses as Topic | 1 | 2009 | 810 | 0.230 |
Why?
|
| Macrophages | 3 | 2018 | 5796 | 0.230 |
Why?
|
| Sepsis | 4 | 2021 | 2601 | 0.230 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2022 | 1855 | 0.230 |
Why?
|
| G1 Phase | 2 | 2009 | 403 | 0.230 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 665 | 0.230 |
Why?
|
| Kinetics | 15 | 2015 | 6333 | 0.230 |
Why?
|
| Photochemistry | 1 | 2004 | 238 | 0.230 |
Why?
|
| Consensus Sequence | 7 | 2011 | 363 | 0.220 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2024 | 148 | 0.220 |
Why?
|
| Oncogenes | 1 | 2009 | 1235 | 0.220 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2024 | 198 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 71 | 0.220 |
Why?
|
| Kupffer Cells | 1 | 2024 | 143 | 0.220 |
Why?
|
| Exoribonucleases | 3 | 2010 | 88 | 0.220 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2012 | 432 | 0.220 |
Why?
|
| Drug Therapy, Combination | 2 | 2018 | 6318 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2019 | 5336 | 0.210 |
Why?
|
| Transfection | 12 | 2011 | 5764 | 0.210 |
Why?
|
| Cell Survival | 6 | 2013 | 5792 | 0.210 |
Why?
|
| Triazoles | 2 | 2019 | 904 | 0.210 |
Why?
|
| Blood Transfusion | 2 | 2020 | 1309 | 0.210 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2023 | 81 | 0.210 |
Why?
|
| Oxidation-Reduction | 3 | 2020 | 2225 | 0.210 |
Why?
|
| Genes, cdc | 1 | 2003 | 114 | 0.210 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1946 | 0.210 |
Why?
|
| Heme | 2 | 2022 | 316 | 0.210 |
Why?
|
| Cell Proliferation | 11 | 2020 | 10478 | 0.210 |
Why?
|
| Immunoblotting | 5 | 2020 | 1647 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 2 | 2013 | 4775 | 0.210 |
Why?
|
| Enzyme Inhibitors | 8 | 2013 | 3722 | 0.210 |
Why?
|
| Rhizobium | 1 | 2022 | 60 | 0.210 |
Why?
|
| Toxoplasmosis | 2 | 2013 | 94 | 0.200 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2010 | 823 | 0.200 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5375 | 0.200 |
Why?
|
| Receptors, Formyl Peptide | 2 | 2020 | 146 | 0.200 |
Why?
|
| Xenopus laevis | 2 | 2020 | 966 | 0.200 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2015 | 2676 | 0.200 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2002 | 24 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 7 | 2022 | 5708 | 0.200 |
Why?
|
| Peptidomimetics | 1 | 2022 | 31 | 0.200 |
Why?
|
| I-kappa B Kinase | 1 | 2003 | 250 | 0.200 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 192 | 0.200 |
Why?
|
| Molecular Structure | 7 | 2022 | 1884 | 0.190 |
Why?
|
| Toxoplasma | 2 | 2013 | 159 | 0.190 |
Why?
|
| Ultraviolet Rays | 4 | 2010 | 1100 | 0.190 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 3939 | 0.190 |
Why?
|
| Isoenzymes | 4 | 2003 | 1684 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2005 | 4357 | 0.190 |
Why?
|
| Lung | 3 | 2017 | 10089 | 0.190 |
Why?
|
| Osteoblasts | 2 | 2014 | 1154 | 0.190 |
Why?
|
| Lysine | 4 | 2015 | 988 | 0.190 |
Why?
|
| Cell Compartmentation | 1 | 2002 | 383 | 0.190 |
Why?
|
| Ribosomes | 1 | 2024 | 499 | 0.190 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3230 | 0.180 |
Why?
|
| Computer Simulation | 6 | 2020 | 6277 | 0.180 |
Why?
|
| Epithelial Cells | 2 | 2012 | 3695 | 0.180 |
Why?
|
| Pleural Effusion | 1 | 2024 | 344 | 0.180 |
Why?
|
| Partial Thromboplastin Time | 1 | 2021 | 204 | 0.180 |
Why?
|
| Cells, Cultured | 14 | 2021 | 19022 | 0.180 |
Why?
|
| beta Catenin | 1 | 2006 | 1047 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2024 | 3813 | 0.180 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2015 | 1197 | 0.180 |
Why?
|
| Radiation, Ionizing | 2 | 2013 | 252 | 0.180 |
Why?
|
| Heat Stroke | 1 | 2020 | 29 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 18048 | 0.170 |
Why?
|
| Protein Precursors | 3 | 1993 | 1134 | 0.170 |
Why?
|
| Hospital Rapid Response Team | 1 | 2020 | 54 | 0.170 |
Why?
|
| Male | 23 | 2024 | 364902 | 0.170 |
Why?
|
| Nanoparticles | 3 | 2018 | 1987 | 0.170 |
Why?
|
| Recombinant Proteins | 12 | 2015 | 6510 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 5 | 2021 | 2636 | 0.170 |
Why?
|
| Symbiosis | 1 | 2022 | 297 | 0.170 |
Why?
|
| Blotting, Western | 5 | 2017 | 5037 | 0.170 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2020 | 116 | 0.170 |
Why?
|
| Multiprotein Complexes | 5 | 2013 | 1110 | 0.170 |
Why?
|
| Drug Synergism | 3 | 2019 | 1762 | 0.170 |
Why?
|
| Quality Indicators, Health Care | 1 | 2009 | 1813 | 0.170 |
Why?
|
| Exocytosis | 1 | 2021 | 323 | 0.160 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12778 | 0.160 |
Why?
|
| Bacteriocins | 2 | 2009 | 85 | 0.160 |
Why?
|
| Female | 39 | 2024 | 397089 | 0.160 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 754 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2019 | 413 | 0.160 |
Why?
|
| Stress, Physiological | 2 | 2012 | 1410 | 0.160 |
Why?
|
| DNA Repair Enzymes | 2 | 2019 | 346 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 6 | 2019 | 6132 | 0.160 |
Why?
|
| DNA | 5 | 2022 | 7211 | 0.160 |
Why?
|
| Middle Aged | 16 | 2024 | 223491 | 0.160 |
Why?
|
| Alternative Splicing | 2 | 2019 | 1093 | 0.160 |
Why?
|
| Macromolecular Substances | 8 | 2005 | 1435 | 0.160 |
Why?
|
| Peptidylprolyl Isomerase | 2 | 2001 | 97 | 0.160 |
Why?
|
| Platelet Activating Factor | 3 | 2004 | 143 | 0.160 |
Why?
|
| Cell Differentiation | 7 | 2017 | 11668 | 0.160 |
Why?
|
| Adult | 17 | 2024 | 223640 | 0.150 |
Why?
|
| Tissue Banks | 1 | 2019 | 184 | 0.150 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 691 | 0.150 |
Why?
|
| Athetosis | 1 | 2018 | 15 | 0.150 |
Why?
|
| Cluster Analysis | 4 | 2021 | 2728 | 0.150 |
Why?
|
| Acids | 1 | 2019 | 125 | 0.150 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 824 | 0.150 |
Why?
|
| Adipocytes | 1 | 2005 | 1200 | 0.150 |
Why?
|
| Chemokines | 1 | 2022 | 962 | 0.150 |
Why?
|
| Quarantine | 1 | 2020 | 187 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2021 | 372 | 0.150 |
Why?
|
| Kinetochores | 3 | 2011 | 180 | 0.150 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 4 | 2018 | 221 | 0.150 |
Why?
|
| Gene Expression Regulation | 11 | 2019 | 11918 | 0.150 |
Why?
|
| Congenital Hypothyroidism | 1 | 2018 | 40 | 0.150 |
Why?
|
| Dipeptides | 1 | 2000 | 386 | 0.150 |
Why?
|
| Public Health Administration | 1 | 2020 | 242 | 0.150 |
Why?
|
| Asthma | 1 | 2017 | 6280 | 0.150 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 492 | 0.150 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2017 | 55 | 0.150 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2017 | 91 | 0.150 |
Why?
|
| Keratinocytes | 2 | 1993 | 876 | 0.150 |
Why?
|
| Protein-Arginine N-Methyltransferases | 2 | 2017 | 129 | 0.150 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2019 | 324 | 0.150 |
Why?
|
| Androstenes | 2 | 2009 | 186 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2024 | 2663 | 0.150 |
Why?
|
| Mammals | 1 | 2023 | 1136 | 0.150 |
Why?
|
| Time Factors | 10 | 2021 | 40272 | 0.150 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2019 | 558 | 0.140 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2007 | 163 | 0.140 |
Why?
|
| Nanomedicine | 1 | 2020 | 292 | 0.140 |
Why?
|
| Citrobacter rodentium | 1 | 2017 | 64 | 0.140 |
Why?
|
| Proline | 2 | 2005 | 455 | 0.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 5422 | 0.140 |
Why?
|
| Chorea | 1 | 2018 | 80 | 0.140 |
Why?
|
| Health Priorities | 1 | 2020 | 380 | 0.140 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 861 | 0.140 |
Why?
|
| Neoplasms, Experimental | 3 | 2014 | 1232 | 0.140 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 423 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 839 | 0.140 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 977 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 4 | 2012 | 4414 | 0.140 |
Why?
|
| Critical Pathways | 1 | 2020 | 476 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2015 | 379 | 0.140 |
Why?
|
| Aged | 10 | 2024 | 171562 | 0.130 |
Why?
|
| Calorimetry | 3 | 2012 | 132 | 0.130 |
Why?
|
| Markov Chains | 1 | 2020 | 977 | 0.130 |
Why?
|
| Doxorubicin | 4 | 2014 | 2229 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2006 | 2460 | 0.130 |
Why?
|
| Breast Neoplasms | 10 | 2019 | 21162 | 0.130 |
Why?
|
| Genomic Instability | 1 | 2020 | 715 | 0.130 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 393 | 0.130 |
Why?
|
| Fungal Proteins | 3 | 2008 | 906 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2018 | 239 | 0.130 |
Why?
|
| Peptide Fragments | 8 | 2005 | 5151 | 0.130 |
Why?
|
| Glutamic Acid | 1 | 2021 | 1193 | 0.130 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2017 | 190 | 0.130 |
Why?
|
| Acetylation | 3 | 2015 | 1053 | 0.130 |
Why?
|
| Boston | 4 | 2020 | 9371 | 0.130 |
Why?
|
| Receptors, IgG | 3 | 2008 | 564 | 0.120 |
Why?
|
| Portraits as Topic | 1 | 2015 | 32 | 0.120 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 408 | 0.120 |
Why?
|
| Androgens | 1 | 2023 | 1285 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 2 | 2016 | 525 | 0.120 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2020 | 621 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 6 | 2019 | 6234 | 0.120 |
Why?
|
| Antigens | 2 | 2019 | 1443 | 0.120 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 18362 | 0.120 |
Why?
|
| Actins | 4 | 2006 | 2059 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.120 |
Why?
|
| Aminopyridines | 1 | 2019 | 580 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2010 | 677 | 0.120 |
Why?
|
| Imidazoles | 2 | 2015 | 1168 | 0.120 |
Why?
|
| Introns | 1 | 2017 | 968 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2015 | 317 | 0.120 |
Why?
|
| Intensive Care Units | 2 | 2020 | 3801 | 0.120 |
Why?
|
| Tretinoin | 1 | 2017 | 525 | 0.120 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 1712 | 0.120 |
Why?
|
| Leukocytes | 1 | 2022 | 2030 | 0.120 |
Why?
|
| HT29 Cells | 2 | 2005 | 190 | 0.120 |
Why?
|
| Goblet Cells | 1 | 2017 | 301 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2014 | 65 | 0.120 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 181 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2013 | 2066 | 0.120 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2018 | 618 | 0.110 |
Why?
|
| Critical Care | 3 | 2020 | 2716 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2019 | 3617 | 0.110 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 590 | 0.110 |
Why?
|
| Phagocytosis | 4 | 2008 | 1530 | 0.110 |
Why?
|
| Static Electricity | 2 | 2005 | 261 | 0.110 |
Why?
|
| GTP-Binding Proteins | 3 | 2013 | 947 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2019 | 1682 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2019 | 682 | 0.110 |
Why?
|
| Internet | 5 | 2010 | 3107 | 0.110 |
Why?
|
| Mass Spectrometry | 6 | 2024 | 2201 | 0.110 |
Why?
|
| Pyridones | 1 | 2019 | 818 | 0.110 |
Why?
|
| Austria | 1 | 2013 | 209 | 0.110 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 42 | 0.110 |
Why?
|
| Models, Theoretical | 3 | 2016 | 3579 | 0.110 |
Why?
|
| Inflammation | 5 | 2022 | 10863 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 3 | 2010 | 224 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1397 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 1484 | 0.110 |
Why?
|
| tRNA Methyltransferases | 1 | 2013 | 50 | 0.110 |
Why?
|
| Osteogenesis | 2 | 2014 | 1295 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2013 | 97 | 0.110 |
Why?
|
| Killer Cells, Natural | 2 | 2020 | 2206 | 0.110 |
Why?
|
| Membrane Proteins | 4 | 2006 | 7880 | 0.110 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2013 | 101 | 0.100 |
Why?
|
| Pyruvate Kinase | 1 | 2014 | 190 | 0.100 |
Why?
|
| Genome | 1 | 2001 | 1747 | 0.100 |
Why?
|
| Transcription, Genetic | 5 | 2021 | 7599 | 0.100 |
Why?
|
| Ovarian Neoplasms | 2 | 2021 | 4907 | 0.100 |
Why?
|
| Mitochondria | 3 | 2021 | 3675 | 0.100 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 742 | 0.100 |
Why?
|
| ROC Curve | 1 | 2020 | 3623 | 0.100 |
Why?
|
| Young Adult | 7 | 2021 | 60049 | 0.100 |
Why?
|
| Neurofibromatosis 2 | 2 | 2008 | 384 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2019 | 864 | 0.100 |
Why?
|
| Disease Management | 2 | 2020 | 2537 | 0.100 |
Why?
|
| Peptoids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Algorithms | 6 | 2015 | 14154 | 0.100 |
Why?
|
| Metabolome | 2 | 2021 | 1008 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 1 | 2019 | 808 | 0.100 |
Why?
|
| Chromatography, Liquid | 2 | 2014 | 997 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 2 | 2009 | 471 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2022 | 2006 | 0.100 |
Why?
|
| Protein Structure, Secondary | 3 | 2000 | 1216 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4588 | 0.100 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2013 | 196 | 0.100 |
Why?
|
| Nucleotides | 1 | 2014 | 455 | 0.100 |
Why?
|
| Epigenomics | 1 | 2018 | 959 | 0.100 |
Why?
|
| Deoxyribonucleases | 1 | 2013 | 209 | 0.100 |
Why?
|
| Cadherins | 2 | 2023 | 906 | 0.100 |
Why?
|
| Caspase 8 | 1 | 2012 | 198 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2014 | 539 | 0.100 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2011 | 23 | 0.100 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.100 |
Why?
|
| Mice, Nude | 4 | 2019 | 3632 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2024 | 1248 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2011 | 1731 | 0.090 |
Why?
|
| Guanine | 1 | 2012 | 280 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2005 | 283 | 0.090 |
Why?
|
| Monocytes | 1 | 2021 | 2595 | 0.090 |
Why?
|
| Bone Neoplasms | 2 | 2018 | 2565 | 0.090 |
Why?
|
| Protein Engineering | 1 | 2015 | 549 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 202 | 0.090 |
Why?
|
| Species Specificity | 4 | 2012 | 2417 | 0.090 |
Why?
|
| Colitis | 1 | 2019 | 1244 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2005 | 1078 | 0.090 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2012 | 93 | 0.090 |
Why?
|
| Glycoproteins | 3 | 2006 | 2204 | 0.090 |
Why?
|
| Synthetic Biology | 1 | 2013 | 187 | 0.090 |
Why?
|
| Glutathione Transferase | 5 | 2007 | 564 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1608 | 0.090 |
Why?
|
| Oximes | 1 | 2012 | 303 | 0.090 |
Why?
|
| Transcriptional Activation | 4 | 2008 | 1748 | 0.090 |
Why?
|
| Isoelectric Focusing | 1 | 2010 | 149 | 0.090 |
Why?
|
| Cytosol | 3 | 2018 | 886 | 0.090 |
Why?
|
| Phenotype | 2 | 2021 | 16721 | 0.090 |
Why?
|
| Alkylation | 3 | 2015 | 84 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 2003 | 826 | 0.090 |
Why?
|
| Phagosomes | 2 | 2008 | 198 | 0.090 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 9198 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1881 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 2006 | 0.080 |
Why?
|
| T-Lymphocytes | 4 | 2022 | 10267 | 0.080 |
Why?
|
| Lipid Metabolism | 2 | 2013 | 1901 | 0.080 |
Why?
|
| MyoD Protein | 1 | 2010 | 141 | 0.080 |
Why?
|
| Cause of Death | 1 | 2020 | 3728 | 0.080 |
Why?
|
| Helping Behavior | 1 | 2009 | 21 | 0.080 |
Why?
|
| Conserved Sequence | 3 | 2005 | 1163 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 1319 | 0.080 |
Why?
|
| Cytostatic Agents | 1 | 2009 | 9 | 0.080 |
Why?
|
| Anaphase | 4 | 2013 | 114 | 0.080 |
Why?
|
| Drug Carriers | 1 | 2014 | 710 | 0.080 |
Why?
|
| COS Cells | 4 | 2008 | 1135 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2014 | 1901 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 755 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2020 | 2906 | 0.080 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2009 | 54 | 0.080 |
Why?
|
| Antibodies, Phospho-Specific | 1 | 2008 | 12 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2917 | 0.080 |
Why?
|
| Cell Membrane | 3 | 2016 | 3663 | 0.080 |
Why?
|
| Metaphase | 1 | 2009 | 145 | 0.080 |
Why?
|
| Sirolimus | 2 | 2013 | 1542 | 0.080 |
Why?
|
| Adenosine Triphosphatases | 1 | 2013 | 841 | 0.080 |
Why?
|
| Cricetinae | 3 | 2013 | 2423 | 0.080 |
Why?
|
| Crime Victims | 1 | 2013 | 347 | 0.080 |
Why?
|
| NIH 3T3 Cells | 4 | 2014 | 669 | 0.080 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2009 | 57 | 0.080 |
Why?
|
| Immune Evasion | 1 | 2012 | 376 | 0.080 |
Why?
|
| Education, Medical | 1 | 2020 | 1742 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2884 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2020 | 4646 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 4 | 2010 | 1623 | 0.080 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2010 | 450 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 515 | 0.080 |
Why?
|
| Repressor Proteins | 3 | 2012 | 2986 | 0.080 |
Why?
|
| Microscopy, Electron | 3 | 2021 | 2559 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 527 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2018 | 3078 | 0.080 |
Why?
|
| Cytochromes | 1 | 2007 | 18 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2011 | 598 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2009 | 170 | 0.080 |
Why?
|
| Flow Cytometry | 5 | 2021 | 5900 | 0.080 |
Why?
|
| Staurosporine | 2 | 2007 | 241 | 0.080 |
Why?
|
| Trans-Activators | 5 | 2018 | 2856 | 0.070 |
Why?
|
| Biosensing Techniques | 1 | 2014 | 661 | 0.070 |
Why?
|
| Liver | 4 | 2024 | 7574 | 0.070 |
Why?
|
| Smad2 Protein | 1 | 2008 | 144 | 0.070 |
Why?
|
| Smad3 Protein | 1 | 2008 | 166 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 440 | 0.070 |
Why?
|
| Quinazolines | 2 | 2014 | 1373 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3139 | 0.070 |
Why?
|
| Patents as Topic | 1 | 2009 | 111 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 427 | 0.070 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 2215 | 0.070 |
Why?
|
| Plasma | 2 | 2021 | 585 | 0.070 |
Why?
|
| Italy | 1 | 2009 | 854 | 0.070 |
Why?
|
| Writing | 1 | 2009 | 200 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2013 | 1575 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2007 | 2911 | 0.070 |
Why?
|
| Data Mining | 1 | 2012 | 560 | 0.070 |
Why?
|
| R-SNARE Proteins | 1 | 2007 | 73 | 0.070 |
Why?
|
| Immunoglobulins | 2 | 2001 | 855 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2019 | 4142 | 0.070 |
Why?
|
| Chromatography, Affinity | 2 | 2008 | 525 | 0.070 |
Why?
|
| Smad4 Protein | 1 | 2008 | 193 | 0.070 |
Why?
|
| Precipitin Tests | 5 | 2007 | 816 | 0.070 |
Why?
|
| Arthritis, Experimental | 1 | 2009 | 293 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 11120 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1151 | 0.070 |
Why?
|
| RNA Caps | 1 | 2007 | 73 | 0.070 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2007 | 83 | 0.070 |
Why?
|
| Crystallization | 2 | 2014 | 521 | 0.070 |
Why?
|
| Biotechnology | 1 | 2009 | 283 | 0.070 |
Why?
|
| Antigens, CD | 4 | 2023 | 4031 | 0.070 |
Why?
|
| Insulin | 5 | 2019 | 6607 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 2237 | 0.070 |
Why?
|
| Shiga Toxin | 1 | 2006 | 36 | 0.070 |
Why?
|
| TRPP Cation Channels | 1 | 2007 | 177 | 0.070 |
Why?
|
| Education | 1 | 2009 | 535 | 0.070 |
Why?
|
| Arginine | 2 | 2000 | 923 | 0.070 |
Why?
|
| Rabbits | 4 | 1999 | 4781 | 0.070 |
Why?
|
| Actomyosin | 1 | 2007 | 114 | 0.070 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2007 | 175 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 3048 | 0.070 |
Why?
|
| Cullin Proteins | 1 | 2007 | 180 | 0.070 |
Why?
|
| Stem Cells | 1 | 2019 | 3539 | 0.070 |
Why?
|
| Epitopes | 3 | 2005 | 2525 | 0.070 |
Why?
|
| Rats | 7 | 2019 | 23835 | 0.070 |
Why?
|
| Dimerization | 2 | 2005 | 886 | 0.070 |
Why?
|
| Epidermal Growth Factor | 2 | 2006 | 698 | 0.070 |
Why?
|
| Zebrafish | 3 | 2022 | 3037 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6406 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 3 | 2019 | 9261 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1658 | 0.060 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2006 | 95 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2014 | 4177 | 0.060 |
Why?
|
| Survival Rate | 1 | 2020 | 12870 | 0.060 |
Why?
|
| Systems Theory | 1 | 2005 | 57 | 0.060 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2005 | 135 | 0.060 |
Why?
|
| F-Box Proteins | 1 | 2007 | 201 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2013 | 2771 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 794 | 0.060 |
Why?
|
| Cattle | 5 | 2001 | 3826 | 0.060 |
Why?
|
| Disease Progression | 2 | 2021 | 13646 | 0.060 |
Why?
|
| Phosphatidylinositols | 1 | 2006 | 280 | 0.060 |
Why?
|
| rho-Associated Kinases | 1 | 2007 | 286 | 0.060 |
Why?
|
| Oxygen | 2 | 2015 | 4273 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 2058 | 0.060 |
Why?
|
| Reticulocytes | 3 | 1992 | 288 | 0.060 |
Why?
|
| Least-Squares Analysis | 1 | 2005 | 368 | 0.060 |
Why?
|
| Xenopus | 2 | 2005 | 710 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2015 | 2929 | 0.060 |
Why?
|
| Lipids | 1 | 2016 | 3344 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 10117 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 770 | 0.060 |
Why?
|
| Salmonella typhimurium | 1 | 2007 | 348 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2005 | 168 | 0.060 |
Why?
|
| X-Ray Diffraction | 2 | 2002 | 417 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2005 | 508 | 0.060 |
Why?
|
| Genetic Vectors | 4 | 2012 | 3413 | 0.060 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 160 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2019 | 3981 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2005 | 277 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2006 | 279 | 0.060 |
Why?
|
| BRCA2 Protein | 1 | 2009 | 802 | 0.060 |
Why?
|
| Organ Size | 1 | 2009 | 2268 | 0.060 |
Why?
|
| Attitude | 1 | 2009 | 772 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 5168 | 0.060 |
Why?
|
| Myosins | 1 | 2006 | 407 | 0.060 |
Why?
|
| raf Kinases | 1 | 2004 | 117 | 0.060 |
Why?
|
| Drosophila | 2 | 2004 | 1514 | 0.060 |
Why?
|
| Zymosan | 1 | 2004 | 134 | 0.060 |
Why?
|
| Adolescent | 5 | 2021 | 89184 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15455 | 0.060 |
Why?
|
| Pseudopodia | 1 | 2004 | 167 | 0.060 |
Why?
|
| Editorial Policies | 1 | 2009 | 459 | 0.060 |
Why?
|
| Phospholipases A | 1 | 2004 | 204 | 0.060 |
Why?
|
| 2-Naphthylamine | 1 | 2003 | 20 | 0.060 |
Why?
|
| Cyclin B | 1 | 2004 | 104 | 0.060 |
Why?
|
| Myoblasts | 2 | 2019 | 233 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2005 | 399 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2012 | 3164 | 0.060 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2003 | 122 | 0.050 |
Why?
|
| Base Sequence | 5 | 2008 | 12422 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2012 | 1614 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 344 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2069 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2024 | 166 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 2012 | 4168 | 0.050 |
Why?
|
| Neurilemmoma | 1 | 2008 | 524 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2009 | 997 | 0.050 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2003 | 87 | 0.050 |
Why?
|
| Breast | 3 | 2003 | 1975 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2013 | 6350 | 0.050 |
Why?
|
| Mammography | 6 | 2003 | 2434 | 0.050 |
Why?
|
| Nitrogenase | 1 | 2022 | 38 | 0.050 |
Why?
|
| Streptolysins | 1 | 2003 | 61 | 0.050 |
Why?
|
| Schizosaccharomyces | 2 | 2004 | 237 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 9562 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 461 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 474 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2003 | 115 | 0.050 |
Why?
|
| Thermodynamics | 3 | 2009 | 591 | 0.050 |
Why?
|
| Luminescent Measurements | 1 | 2004 | 343 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2003 | 247 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39407 | 0.050 |
Why?
|
| PPAR gamma | 1 | 2005 | 487 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 478 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2008 | 1614 | 0.050 |
Why?
|
| Swine | 3 | 2004 | 5994 | 0.050 |
Why?
|
| Gamma Rays | 1 | 2003 | 319 | 0.050 |
Why?
|
| Neurofibromin 2 | 1 | 2003 | 271 | 0.050 |
Why?
|
| Glioblastoma | 2 | 2008 | 3526 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2009 | 4209 | 0.050 |
Why?
|
| Publishing | 1 | 2009 | 836 | 0.050 |
Why?
|
| Leukotriene B4 | 2 | 2018 | 281 | 0.050 |
Why?
|
| Myosin Light Chains | 2 | 2012 | 122 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 81801 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2005 | 1251 | 0.050 |
Why?
|
| Sirtuins | 1 | 2005 | 322 | 0.050 |
Why?
|
| Protein Folding | 2 | 2005 | 872 | 0.050 |
Why?
|
| Fanconi Anemia | 1 | 2024 | 327 | 0.050 |
Why?
|
| Surface Properties | 1 | 2004 | 1167 | 0.050 |
Why?
|
| Chickens | 3 | 2000 | 845 | 0.050 |
Why?
|
| Half-Life | 2 | 2015 | 650 | 0.050 |
Why?
|
| Karyopherins | 1 | 2002 | 134 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2017 | 507 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 2003 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 694 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 26375 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1249 | 0.050 |
Why?
|
| Annual Reports as Topic | 1 | 2020 | 36 | 0.050 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 326 | 0.050 |
Why?
|
| Nitrogen | 1 | 2022 | 345 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9742 | 0.050 |
Why?
|
| Alanine | 1 | 2003 | 613 | 0.040 |
Why?
|
| Prescriptions | 1 | 2023 | 388 | 0.040 |
Why?
|
| Naphthyridines | 2 | 2013 | 181 | 0.040 |
Why?
|
| CHO Cells | 2 | 2013 | 1380 | 0.040 |
Why?
|
| RGS Proteins | 1 | 2000 | 76 | 0.040 |
Why?
|
| Leucine | 1 | 2002 | 548 | 0.040 |
Why?
|
| Antibodies | 1 | 2008 | 2425 | 0.040 |
Why?
|
| Cyclosporine | 2 | 2020 | 779 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65379 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3794 | 0.040 |
Why?
|
| Biological Assay | 1 | 2003 | 627 | 0.040 |
Why?
|
| Phylogeny | 2 | 2005 | 2843 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2005 | 717 | 0.040 |
Why?
|
| Chromatography, Gel | 1 | 2021 | 637 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 10776 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2018 | 4120 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 848 | 0.040 |
Why?
|
| Escherichia coli | 4 | 2012 | 4211 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2000 | 317 | 0.040 |
Why?
|
| Integrins | 1 | 2004 | 843 | 0.040 |
Why?
|
| United States | 3 | 2020 | 73150 | 0.040 |
Why?
|
| Growth Substances | 1 | 2002 | 761 | 0.040 |
Why?
|
| Glycolysis | 1 | 2024 | 838 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2001 | 1086 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 3 | 2005 | 5801 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2020 | 239 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 3612 | 0.040 |
Why?
|
| Genes, Reporter | 4 | 2008 | 1524 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 2001 | 366 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2007 | 1628 | 0.040 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2019 | 56 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 444 | 0.040 |
Why?
|
| Blood Viscosity | 1 | 2019 | 125 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2024 | 853 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2005 | 1019 | 0.040 |
Why?
|
| Caffeine | 1 | 2003 | 702 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 2018 | 47 | 0.040 |
Why?
|
| Cyclization | 1 | 2018 | 59 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 98 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2023 | 696 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2018 | 102 | 0.040 |
Why?
|
| Calcineurin | 1 | 1999 | 236 | 0.040 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2019 | 241 | 0.040 |
Why?
|
| Amino Acid Isomerases | 1 | 1997 | 31 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 855 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2000 | 294 | 0.040 |
Why?
|
| Guanosine Triphosphate | 3 | 2006 | 315 | 0.040 |
Why?
|
| Tryptophan | 1 | 2000 | 482 | 0.040 |
Why?
|
| Heart | 1 | 2011 | 4449 | 0.040 |
Why?
|
| Muscle Cells | 1 | 2019 | 195 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 1996 | 288 | 0.040 |
Why?
|
| Mutant Proteins | 2 | 2010 | 489 | 0.040 |
Why?
|
| Isomerism | 1 | 1997 | 198 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 3 | 2012 | 1337 | 0.040 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1997 | 122 | 0.040 |
Why?
|
| Point Mutation | 1 | 2003 | 1594 | 0.040 |
Why?
|
| Cysteine | 1 | 2022 | 895 | 0.040 |
Why?
|
| Electron Transport Complex I | 1 | 2018 | 153 | 0.040 |
Why?
|
| Cyanogen Bromide | 3 | 1993 | 75 | 0.040 |
Why?
|
| Catalysis | 1 | 2019 | 768 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 13576 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4427 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 2257 | 0.030 |
Why?
|
| Terminology as Topic | 2 | 2019 | 1539 | 0.030 |
Why?
|
| Protozoan Proteins | 2 | 2013 | 844 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2475 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2020 | 2673 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 1997 | 199 | 0.030 |
Why?
|
| Quality Control | 1 | 2019 | 833 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 948 | 0.030 |
Why?
|
| Simvastatin | 1 | 2019 | 346 | 0.030 |
Why?
|
| Micelles | 1 | 2017 | 191 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2003 | 1226 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 354 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 2923 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2017 | 354 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1998 | 259 | 0.030 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1998 | 501 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1999 | 529 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 1995 | 113 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1837 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 566 | 0.030 |
Why?
|
| Trypsin | 2 | 2003 | 491 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2023 | 1885 | 0.030 |
Why?
|
| Lung Injury | 1 | 2020 | 433 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1866 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2019 | 1229 | 0.030 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2014 | 15 | 0.030 |
Why?
|
| Esterases | 1 | 2014 | 89 | 0.030 |
Why?
|
| Dihydrouracil Dehydrogenase (NADP) | 1 | 2014 | 17 | 0.030 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 2 | 2006 | 43 | 0.030 |
Why?
|
| Anions | 1 | 2014 | 137 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2014 | 219 | 0.030 |
Why?
|
| Fluorescence Polarization | 1 | 2014 | 139 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 720 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1298 | 0.030 |
Why?
|
| Jurkat Cells | 3 | 2000 | 738 | 0.030 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 1993 | 8 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 1997 | 797 | 0.030 |
Why?
|
| Burns | 2 | 1996 | 1893 | 0.030 |
Why?
|
| Focal Adhesions | 2 | 2004 | 114 | 0.030 |
Why?
|
| Iron | 1 | 2022 | 1814 | 0.030 |
Why?
|
| Chaperonins | 1 | 1993 | 58 | 0.030 |
Why?
|
| Bacterial Proteins | 2 | 2007 | 3838 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 998 | 0.030 |
Why?
|
| Amino Acids | 3 | 2013 | 1716 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 1238 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2021 | 5496 | 0.030 |
Why?
|
| Drug Stability | 1 | 2013 | 291 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 2009 | 1142 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11854 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1141 | 0.030 |
Why?
|
| Chromones | 1 | 2013 | 148 | 0.030 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 4981 | 0.030 |
Why?
|
| t-Complex Genome Region | 1 | 1992 | 5 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2009 | 484 | 0.030 |
Why?
|
| International Cooperation | 1 | 2019 | 1438 | 0.030 |
Why?
|
| N-substituted Glycines | 1 | 2012 | 2 | 0.030 |
Why?
|
| Base Pair Mismatch | 1 | 2012 | 93 | 0.030 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2013 | 111 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 2015 | 1894 | 0.030 |
Why?
|
| Esters | 1 | 2013 | 212 | 0.030 |
Why?
|
| Dietary Fats | 2 | 1998 | 2003 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2021 | 22296 | 0.030 |
Why?
|
| Sonication | 1 | 1993 | 79 | 0.030 |
Why?
|
| Pulmonary Emphysema | 1 | 2018 | 690 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2005 | 505 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 1993 | 193 | 0.020 |
Why?
|
| Cell Death | 2 | 2012 | 1682 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1992 | 342 | 0.020 |
Why?
|
| Pyridines | 1 | 2004 | 2889 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2012 | 137 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 1997 | 896 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2006 | 458 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 1992 | 337 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 1014 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2022 | 2476 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2004 | 461 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 891 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 1993 | 164 | 0.020 |
Why?
|
| Neurons | 2 | 2008 | 9513 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 4039 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 1033 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1468 | 0.020 |
Why?
|
| Temperature | 2 | 2010 | 2235 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 1539 | 0.020 |
Why?
|
| Multigene Family | 2 | 2005 | 1082 | 0.020 |
Why?
|
| Bacteria | 1 | 2022 | 2221 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2011 | 125 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2011 | 135 | 0.020 |
Why?
|
| Mesoderm | 1 | 2014 | 679 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 2 | 2001 | 114 | 0.020 |
Why?
|
| Culture Media | 1 | 2013 | 898 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 190 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2012 | 270 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2012 | 277 | 0.020 |
Why?
|
| Solubility | 1 | 1993 | 1085 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3211 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2000 | 2568 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1995 | 880 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1992 | 342 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3633 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2017 | 0.020 |
Why?
|
| Myogenin | 1 | 2010 | 54 | 0.020 |
Why?
|
| Electroosmosis | 1 | 2010 | 8 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2010 | 290 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 419 | 0.020 |
Why?
|
| Microtubules | 2 | 1986 | 1071 | 0.020 |
Why?
|
| Liposomes | 1 | 2014 | 792 | 0.020 |
Why?
|
| Butadienes | 1 | 2010 | 107 | 0.020 |
Why?
|
| Disulfides | 1 | 1992 | 467 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2019 | 2574 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 1990 | 114 | 0.020 |
Why?
|
| Phospholipase C gamma | 2 | 2000 | 131 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 731 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1992 | 2172 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 1839 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3587 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 293 | 0.020 |
Why?
|
| Morpholines | 1 | 2013 | 584 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2010 | 135 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2990 | 0.020 |
Why?
|
| Type C Phospholipases | 2 | 2000 | 287 | 0.020 |
Why?
|
| Spodoptera | 1 | 2009 | 140 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2632 | 0.020 |
Why?
|
| General Surgery | 1 | 2020 | 1713 | 0.020 |
Why?
|
| Carbocyanines | 1 | 2009 | 175 | 0.020 |
Why?
|
| Catenins | 1 | 2008 | 44 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 2442 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 1674 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 413 | 0.020 |
Why?
|
| Ear | 1 | 2009 | 172 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2846 | 0.020 |
Why?
|
| Virulence | 1 | 2012 | 1298 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2014 | 1913 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 1988 | 137 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2008 | 323 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2020 | 3960 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 4785 | 0.020 |
Why?
|
| Microtubule Proteins | 1 | 1988 | 62 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4921 | 0.020 |
Why?
|
| Peritoneum | 1 | 2009 | 231 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 1221 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 13020 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14737 | 0.020 |
Why?
|
| Mediator Complex | 1 | 2008 | 106 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2012 | 1090 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2010 | 427 | 0.020 |
Why?
|
| Androstadienes | 1 | 2009 | 348 | 0.020 |
Why?
|
| NFATC Transcription Factors | 2 | 2000 | 393 | 0.020 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2007 | 67 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 574 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1889 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2023 | 4843 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 2825 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2008 | 395 | 0.020 |
Why?
|
| Albumins | 1 | 2010 | 577 | 0.020 |
Why?
|
| Glucose | 1 | 2019 | 4352 | 0.020 |
Why?
|
| Alkaloids | 1 | 1988 | 192 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 424 | 0.020 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 12092 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 84 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 1139 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2008 | 1065 | 0.020 |
Why?
|
| Cyclins | 1 | 2009 | 606 | 0.020 |
Why?
|
| Homeostasis | 1 | 2017 | 3349 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2006 | 35 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 1395 | 0.020 |
Why?
|
| Dendrites | 1 | 2008 | 472 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15872 | 0.020 |
Why?
|
| Ubiquitins | 1 | 2007 | 366 | 0.020 |
Why?
|
| Vero Cells | 1 | 2006 | 486 | 0.020 |
Why?
|
| Phagocytes | 1 | 2007 | 294 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1195 | 0.020 |
Why?
|
| Methylation | 3 | 2000 | 1076 | 0.020 |
Why?
|
| Netherlands | 1 | 2010 | 2274 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 30022 | 0.020 |
Why?
|
| Calcium | 1 | 2018 | 5794 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2007 | 414 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2001 | 8075 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2020 | 3858 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1742 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2488 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2009 | 2299 | 0.020 |
Why?
|
| Succinimides | 1 | 2005 | 83 | 0.020 |
Why?
|
| Ionomycin | 1 | 2004 | 110 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 405 | 0.010 |
Why?
|
| Streptavidin | 1 | 2005 | 81 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1992 | 2940 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2005 | 287 | 0.010 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2006 | 269 | 0.010 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2004 | 58 | 0.010 |
Why?
|
| Nitriles | 1 | 2010 | 984 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 2004 | 197 | 0.010 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 231 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 4788 | 0.010 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2004 | 30 | 0.010 |
Why?
|
| Vaccinia | 1 | 2004 | 71 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2019 | 6430 | 0.010 |
Why?
|
| Genes | 1 | 1988 | 1824 | 0.010 |
Why?
|
| Plasmids | 2 | 2004 | 2268 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2012 | 1266 | 0.010 |
Why?
|
| Biochemistry | 1 | 2005 | 116 | 0.010 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2004 | 98 | 0.010 |
Why?
|
| Paxillin | 1 | 2003 | 86 | 0.010 |
Why?
|
| Biotin | 1 | 2005 | 256 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2010 | 1532 | 0.010 |
Why?
|
| Wisconsin | 1 | 2003 | 122 | 0.010 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 153 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2009 | 1110 | 0.010 |
Why?
|
| Sirtuin 1 | 1 | 2005 | 247 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 710 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 2004 | 429 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2005 | 583 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2003 | 205 | 0.010 |
Why?
|
| Carcinoma | 1 | 2014 | 2341 | 0.010 |
Why?
|
| Endometrial Neoplasms | 1 | 2012 | 1382 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3102 | 0.010 |
Why?
|
| Pyrrolidines | 1 | 2004 | 340 | 0.010 |
Why?
|
| Naphthalenes | 1 | 2003 | 198 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2006 | 524 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2006 | 640 | 0.010 |
Why?
|
| Mitogens | 1 | 2002 | 229 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2006 | 572 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2006 | 943 | 0.010 |
Why?
|
| Tristetraprolin | 1 | 2002 | 40 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2004 | 761 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2004 | 617 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2002 | 260 | 0.010 |
Why?
|
| Nucleosomes | 1 | 2005 | 489 | 0.010 |
Why?
|
| Astrocytoma | 1 | 2006 | 780 | 0.010 |
Why?
|
| Smad Proteins | 1 | 2002 | 157 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2001 | 121 | 0.010 |
Why?
|
| Lentivirus | 1 | 2004 | 519 | 0.010 |
Why?
|
| Obesity | 1 | 2024 | 13084 | 0.010 |
Why?
|
| Phosphoamino Acids | 1 | 2000 | 6 | 0.010 |
Why?
|
| Receptors, Cell Surface | 2 | 2001 | 2819 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2007 | 1397 | 0.010 |
Why?
|
| Environmental Pollutants | 1 | 2010 | 1290 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6085 | 0.010 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2000 | 69 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2002 | 415 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 1131 | 0.010 |
Why?
|
| Prolactin | 1 | 2002 | 626 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1988 | 1736 | 0.010 |
Why?
|
| Diet | 1 | 1998 | 8090 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2000 | 102 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 2394 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2002 | 554 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2005 | 731 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1905 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2005 | 1165 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2020 | 54920 | 0.010 |
Why?
|
| Detergents | 1 | 2000 | 235 | 0.010 |
Why?
|
| Epithelium | 1 | 2004 | 1609 | 0.010 |
Why?
|
| Yeasts | 1 | 2000 | 279 | 0.010 |
Why?
|
| Guanosine Diphosphate | 2 | 1990 | 79 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2015 | 4738 | 0.010 |
Why?
|
| Hybridomas | 1 | 2000 | 444 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41795 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4450 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2000 | 412 | 0.010 |
Why?
|
| Premenopause | 1 | 2002 | 1039 | 0.010 |
Why?
|
| Progesterone | 1 | 2002 | 751 | 0.010 |
Why?
|
| Gene Library | 1 | 2000 | 1061 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 662 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26411 | 0.010 |
Why?
|
| Methyltransferases | 1 | 2000 | 373 | 0.010 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2003 | 887 | 0.010 |
Why?
|
| NFI Transcription Factors | 1 | 1996 | 42 | 0.010 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 1996 | 41 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1996 | 226 | 0.010 |
Why?
|
| Ion Transport | 1 | 1997 | 322 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6892 | 0.010 |
Why?
|
| Ultrasonography, Mammary | 1 | 1998 | 241 | 0.010 |
Why?
|
| Lactation | 1 | 1998 | 397 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 1926 | 0.010 |
Why?
|
| Estradiol | 1 | 2002 | 1952 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 1994 | 27 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2002 | 1943 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1998 | 708 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 1994 | 93 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 1994 | 127 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1409 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 1994 | 174 | 0.010 |
Why?
|
| Postmenopause | 1 | 2002 | 2518 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1992 | 58 | 0.010 |
Why?
|
| Pneumonia | 1 | 2004 | 2163 | 0.010 |
Why?
|
| Brefeldin A | 1 | 1992 | 68 | 0.010 |
Why?
|
| Brain | 3 | 1989 | 27454 | 0.010 |
Why?
|
| Cyclopentanes | 1 | 1992 | 87 | 0.010 |
Why?
|
| Transglutaminases | 1 | 1993 | 200 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7064 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1994 | 325 | 0.010 |
Why?
|
| Risk Factors | 4 | 2002 | 74962 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2003 | 1929 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1997 | 1122 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1993 | 611 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2003 | 2293 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1994 | 891 | 0.010 |
Why?
|
| Anthropometry | 1 | 1995 | 1343 | 0.010 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1990 | 293 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1994 | 1967 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 4941 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5831 | 0.000 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2000 | 4411 | 0.000 |
Why?
|
| Diethyl Pyrocarbonate | 1 | 1986 | 5 | 0.000 |
Why?
|
| Nutritional Status | 1 | 1995 | 1627 | 0.000 |
Why?
|
| Magnesium | 1 | 1990 | 816 | 0.000 |
Why?
|
| Ethyldimethylaminopropyl Carbodiimide | 1 | 1986 | 6 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 8199 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 10377 | 0.000 |
Why?
|
| Incidence | 1 | 2003 | 21544 | 0.000 |
Why?
|
| Skin | 1 | 1993 | 4499 | 0.000 |
Why?
|
| Pregnancy | 1 | 1998 | 30200 | 0.000 |
Why?
|
| Child | 1 | 2003 | 80891 | 0.000 |
Why?
|